A new type of blood component separator (BCS) was used for the isolation of hematopoietic progenitor cells from human bone marrow aspirates. The BCS was filled with 100-150 ml bone marrow and centrifuged to prepare a buffy coat. This buffy coat was isolated in 10-15% of the original bone marrow volume and contained 64 ± 8% of the nucleated cells (NC). Morphological examination revealed that the buffy coat was highly enriched for myeloblasts, promyelocytes, lymphocytes and monocytes, v/hereas the contamination with granulocytes was reduced to 46 ± 8% of the granulocytes initially present in the bone marrow suspension. In addition the contamination with red blood cells (RBC) was very low; the buffy coat contained only 6 ±2% of the RBC. Furthermore it was demonstrated by means of colony assays that the buffy coat was highly enriched for hematopoietic progenitor cells. It contained 91 ± 6% of the granulocyte/monocyte progenitor cells (CFU-GM) and 87 ± 9% o f the erythroid progenitor cells (BFU-E). These results are comparable to those obtained with continuous or semicontinuous blood cell processors. The advantages of the BCS is that it is a simple and inexpensive apparatus which fits in a normal blood bank centrifuge. It permits efficient preparation and isolation of a buffy coat from human bone marrow without sub stantial loss of hematopoietic progenitor cells.
Introduction
Bone marrow failure, as a result of anti cancer therapy, is often treated by reinfusing cryopreserved autologous bone marrow. To facilitate storage, reconstitution and in vitro manipulation, various methods have been developed to concentrate the marrow cells.
Most investigators use semicontinuous Weiner et al.? 1977; Ma and Biggs, 1982;  Van de Ouwelandet al., 1982] or continuous [Gilmore et al., 1983] centrifugation proce dures to prepare a buffy coat from the bone marrow suspension to remove red blood cells (RBC) and granulocytes. However, since these techniques are rather expensive and require skillful personnel they are gen erally applied in the larger medical centers only.
Density gradient centrifugation has also been used to isolate the mononuclear cell fraction (inluding the hematopoietic pro genitor cells) from bone marrow suspensions [Dicke et al., 1968; Wells et al., 1979] . How ever, the number of cells that can be applied to a density gradient is limited. Gilmore et al. [1982] solved this problem by first preparing a buffy coat in an IBM 2991 blood cell pro cessor to reduce the cell number and subse quently isolating the mononuclear cells us ing Ficoll/metrizoate in the same apparatus.
We recently developed a prototype of an inexpensive blood component separator (BCS) [Figdorti al., 1982a, b] . This sandglass resembling apparatus fitted in a normal pre parative bloodbank centrifuge and was used to prepare buffy coats from peripheral blood. After centrifugation, the buffy coat was fractionated in a fraction containing pure platelets and a mononuclear cell frac tion containing only 3% granulocytes.
In the present communication it is shown that the BCS is also perfectly suited for the isolation of hematopoietic progenitor cells from bone marrow cells.
Materials and Methods

Bone Marrow Aspiration
Bone marrow was harvested for cryopreservation under general or epidural anesthesia from the posterior iliac crests of 9 patients (acute leukaemia in first rem ission) in disposable syringes (10 ml) containing 1ml acidic citrate dextrose (ACD) and 50IU preservative free heparin. The marrow was filtered (70|im pore size) and collected in transfer bags. 100-150 ml (10%) of the bone marrow suspension was separated as described below. The remainder was processed routinely by means of a haemonetics model 30 cell separator and cry op reserved, as described previously [Van de Ouweland el al., 1982] ,
Cell Separation
A buffy coat was prepared from bone marrow aspi rates by means of a recently developed BCS [Figdor et al, 1982a] , This sandglass resembling apparatus was made of glass and consists of an upper (180 ml) and lower (150 ml) compartment connected by a narrow tube. The device was filled with 100-150 ml of a bone marrow suspension that was diluted with an equal vol ume of phosphate-buffered saline containing 15% ACD.
In some experiments we added to this suspension 10% Plasmasteril (Fresenius, Bad Homburg, FRG), which contained 6% hydroxyethyl starch (HES) as a rouleauforming agent.
The volume of the lower compartment of the BCS was adjusted to the hematocrit in such a way that after centrifugation (30min, 500g at room temperature) the buffy coat was formed just below the narrow tube ( fig. la ).To this end we injected Maxidens (MD; Nyegaard and Co., Oslo, Norway) into the lower compart ment, MD is a nontoxic autoclavable fluid that is immiscible with aqueous solutions and has a density of 1.9g/mL The volume of MD required could be calcu lated after determination of the hematocrit of the bone marrow suspension. After centrifugation, a fractiona tion device is screwed on top of the apparatus (fig, lb) . Fractionation is accomplished by the simultaneous in troduction of NaCl in the upper compartment and md in the lower compartment. This procedure has the advantage that the plasma acts as a sheath flow sur rounding the buffy coat cells, and thus prevents sticking of these cells to the wall of the outlet tube. In addition the buffy coat cells were collected in autologous plasma. Five fractions were collected at the outlet. Fractions 1-4 had a volume of 5 ml each, fraction 5 which contained the remaining RBC layer and the plasma had a volume of 1.80-280 ml.
The whole procedure including centrifugation and collection of the various fractions took less than 90min. 
Cell Counting and Morphology
The number of RBC and nucleated cells (NC) was determined by means of a Coulter Counter Model ZF (Coulter Electronics Ltd, Dunstable, Beds., UK).
The morphology was examined on cy to centrifuge preparations after staining with May-Griinewald Giemsa.
Committed Stem Cell Assays
Granulocyte-macrophage colony forming cells (GFU-GM) and erythroid colony forming cells (BFU-E) were determined as described previously [De Witte et al., 1984] . Briefly, the number of GFU-GM was deter mined after incubation of 1-2x105 cells in 2 ml semi solid agar (Difco) containing 4% placenta conditioned medium and 20% fetal calf serum (FCS) for a period of 10-12 days. Aggregates of 40 and more cells were counted as colonies.
The number of BFU-E was determined by incubat ing 1x105 cells/ml in Iscove's modified Dulbecco's medium (IMDM, Gibco 78-5220) containing 0.8% methlylcellulose (Fluka, Schweiz), 10~4 M thyoglycerol, 10% BSA (Sigma), 20% FCS (Rehatain), 20% leu kocyte conditioned medium and 2 units sheep erythro poietin (Connaught Medical Research Laboratories). Orange to red colonies of at least three subclusters or one single colony of more than 300 cells were scored as BFU-E on day 14 of the culture. Before culture, a sam ple of the original bone marrow suspension and fraction five were centrifuged over Ficoll/Isopaque with a den sity of 1,085 to remove most of the RBC.
Results
Bone marrow was aspirated from acute leukemia patients in first remission. Figure 2a the CFU-GM and 87 ± 9% of the BFU-E initially present in the bone marrow suspen sion. In addition the buffy coat was contamthat the RBC contamination was very low in inated with only 6 ± 2% of the RBC and the first three fractions. The RBC/NC ratio 46 ± 8% of the granulocytes initially present increased from 10 ± 4 in fraction 1 to in the original bone marrow aspirate 540 ± 105 in fraction 5. The distribution of (fig. 3) 
100-150 ml of the bone marrow suspension which contained 980-1,870xl06 NC was centrifuged in the BCS and fractionated into five fractions. The buffy coat was isolated in fractions 1-3, fraction 4 was an intermediate fraction, and fraction 5 contained both the remaining plasma and the RBC layer (in cluding the remaining granulocytes). These 5 fractions cotained 95 ±7% of the NC. The distribution of the NC in the various frac tions is shown in
The buffy coat which was collected in the
. the hematopoietic progenitor cells (CFU-
In some experiments we added HES to GM)> which is shown in figure 2d , demon-the bone marrow suspension prior to centri strated that most of the CFU-GM were re-fugation. The results obtained with these covered in fractions 1, 2 and 3. bone marrow suspensions did not differ sig- J £> normoblasts myelocytes were distributed equally over fractions 1-5. The number of granulocytes gradually increased with the fraction num ber, while in contrast the majority of the lymphocytes (91 ±5% ) and monocytes (89 ±8%) was recovered in fractions 1-3. The normoblasts were distributed equally over all five fractions.
Discussion
The aim of the present study was to inves tigate whether the BCS could be used for the isolation of hematopoietic progenitor cells by preparing a buffy coat from human bone marrow. The results demonstrated that ap proximately 90% of the CFU-GM and BFU-E could be isolated in a buffy coat (fraction 1-3) in a volume of only 10-15% of the orig inal bone marrow aspirate. In addition the buffy coat contained more than 90% of the mononuclear cells and only 6 ± 2% and 46 ± 8% of the RBC and granulocytes, re spectively.
The addition of a rouleau-forming agent to the bone marrow suspension did not re sult in a better separation. Furthermore we found that the optimal temperature to sepa rate bone marrow with the BCS was 25-30 °C (not shown et al., 1983] . The BCS is a The morphological characterization of simple and inexpensive apparatus and has the cells in the various fractions is shown in the advantage that it can be used in normal figure 4. Both myeloblasts and promyelo-blood bank centrifuges. It does not need specytes were highly enriched in fractions 1-3 daily trained personnel and could therefore (9 5 ±4% were recovered in fractions 1-3, also be applied in the smaller medical cenrespectively) while myelocytes and meta-ters. [Filipovich et al.5 1982; Prentice et al., 1982] , or to remove tumor cells that contam inate autologous bone marrow from cancer patients [Buckman et al., 1982; Treleaven et al.3 1984] . To obtain optimal results it is essential to concentrate the bone marrow progenitor cells as much as possible prior to in vitro manipulation. For this purpose the BCS seems to be suited extremely well.
Bone marrow may be manipulated in vi tro prior to infusion into the patient: either to remove T cells from allogeneic bone mar row in order to prevent graft-versus-host dis ease
Until now the prototype of the BCS used in this study can process a volume of up to 150 ml o f bone marrow aspirate. However, volumes that have to be processed for clini cal use ( bone marrow transplantations) are much larger, 800-1,200 ml in general. Therefore, we recently started the develop ment of a larger and disposable version of the BCS by means of which volumes of up to 600 ml can be separated and that also fits in a bucket o f a normal blood bank centrifuge.
In our opinion a clinically applicable ver sion of the BCS might further complete the scale of techniques currently available to separate bone marrow, since it allows the efficient isolation of bone marrow progeni tor cells under sterile conditions by simple means.
